跳至主要内容
临床试验/NCT04590742
NCT04590742Unknown不适用

Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty

Rothman Institute Orthopaedics1 个研究点 分布在 1 个国家目标入组 154 人开始时间: 2018年2月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
154
试验地点
1
主要终点
Patient Sleep Quality

研究概览

简要总结

The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who undergo unilateral primary total joint arthroplasty
  • Patient willing and able to complete postoperative surveys

排除标准

  • Patients who undergo revision total joint arthroplasty
  • Patients who undergo bilateral total joint arthroplasty
  • Patients currently taking melatonin supplementation
  • Patient has history of substance abuse (drug or alcohol)
  • Patient is a workman's comp patient or patient has current litigation pending
  • Patient has an allergy to melatonin
  • Patient has a history of delirium/psychiatric/depression/on antidepressants
  • Patient has a history of insomnia/ on sleep aid medication
  • Anyone on warfarin
  • Sleep apnea
  • Patient discharged to SNF or rehab
  • Patients who have inflammatory conditions
  • Shift work or night work

研究组 & 干预措施

Group 1

Placebo Comparator

Placebo Tablet

干预措施: Placebo (Drug)

Group 2

Active Comparator

Melatonin (6mg)

干预措施: melatonin 6mg (Drug)

结局指标

主要结局

Patient Sleep Quality

时间窗: 6 weeks

Patients quality of sleep will be analyzed by having them answer a sleep quality index (PSQI) questionnaires

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Randomized Trial Investigating Melatonin... | 临床试验